Page last updated: 2024-09-04

levofloxacin and Infection

levofloxacin has been researched along with Infection in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (50.00)	29.6817
2010's	5 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belsham, E; Bowcock, S; Campbell, G; Dawkins, B; Dignum, H; Drayson, MT; Dunn, JA; Hamblin, M; Harrison, B; Hawkey, P; Higgins, H; Hulme, CT; Iqbal, G; Karunanithi, K; Lokare, A; Low, E; Meads, D; Monahan, I; Neilson, J; Planche, T; Pratt, G; Raynes, K; Whittaker, AC; Wood, J; Yong, K	1
Ramasamy, K	1
Bilker, W; Bink, K; Fitzpatrick, R; Gilmar, C; Gorman, T; Han, JH; Kraus, K; Kucharczuk, C; Landsburg, D; Mangan, P; Moore, A; Pegues, D; Stadtmauer, EA; Ziegler, M	1
Colilla, M; Izquierdo-Barba, I; Martínez-Carmona, M; Vallet-Regí, M	1
Ahn, JS; Jang, HC; Jung, SH; Kang, SJ; Kim, HJ; Kim, YK; Lee, JJ; Lee, SS; Yang, DH	1
Budanov, SV	1
Alvarez Lerma, F; Bermejo, B; Leon, C; Olaechea, P; Palomar, M; Sanchez, M	1
Graninger, W; Zeitlinger, M	1
Cervera, A; Chamorro, A; Horcajada, JP; Mensa, J; Obach, V; Planas, AM; Revilla, M; Torres, F; Vargas, M	1
Gutierrez-Solana, M; Karaniewsky, R; Tumminello, B	1

Reviews

1 review(s) available for levofloxacin and Infection

Article	Year
Clinical applications of levofloxacin for severe infections. Chemotherapy, 2004, Volume: 50 Suppl 1 Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Epithelium; Humans; Infections; Levofloxacin; Lung; Ofloxacin	2004

Trials

2 trial(s) available for levofloxacin and Infection

Article	Year
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial. The Lancet. Oncology, 2019, Volume: 20, Issue:12 Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Double-Blind Method; Febrile Neutropenia; Female; Follow-Up Studies; Humans; Infections; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Prognosis; Prospective Studies	2019
The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. Stroke, 2005, Volume: 36, Issue:7 Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Body Temperature; Brain; Brain Ischemia; C-Reactive Protein; Double-Blind Method; Female; Humans; Infections; Ischemia; Leukocytes; Levofloxacin; Male; Middle Aged; Odds Ratio; Ofloxacin; Placebos; Risk; Stroke; Time Factors; Treatment Outcome	2005

Article

Year

Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.

The Lancet. Oncology, 2019, Volume: 20, Issue:12

Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Double-Blind Method; Febrile Neutropenia; Female; Follow-Up Studies; Humans; Infections; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Prognosis; Prospective Studies

2019

The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial.

Stroke, 2005, Volume: 36, Issue:7

Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Body Temperature; Brain; Brain Ischemia; C-Reactive Protein; Double-Blind Method; Female; Humans; Infections; Ischemia; Leukocytes; Levofloxacin; Male; Middle Aged; Odds Ratio; Ofloxacin; Placebos; Risk; Stroke; Time Factors; Treatment Outcome

2005

Other Studies

7 other study(ies) available for levofloxacin and Infection

Article	Year
Reducing infection-related morbidity and mortality in patients with myeloma. The Lancet. Oncology, 2019, Volume: 20, Issue:12 Topics: Diphosphonates; Double-Blind Method; Humans; Infections; Levofloxacin; Multiple Myeloma	2019
Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019, Volume: 25, Issue:5 Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Clostridium Infections; Febrile Neutropenia; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infection Control; Infections; Levofloxacin; Male; Middle Aged; Sepsis; Transplantation, Autologous	2019
Concanavalin A-targeted mesoporous silica nanoparticles for infection treatment. Acta biomaterialia, 2019, 09-15, Volume: 96 Topics: Animals; Cell Line; Concanavalin A; Infections; Levofloxacin; Mice; Nanoparticles; Porosity; Silicon Dioxide	2019
Effect of levofloxacin prophylaxis for prevention of severe infections in multiple myeloma patients receiving bortezomib-containing regimens. International journal of hematology, 2014, Volume: 100, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Comorbidity; Female; Humans; Incidence; Infections; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Pyrazines; Treatment Outcome	2014
[Safety of floracid (levofloxacin), a Russian antimicrobial, in the treatment of outpatients]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2009, Volume: 54, Issue:11-12 Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Bacterial Agents; Drugs, Generic; Female; Humans; Infections; Levofloxacin; Male; Middle Aged; Moscow; Ofloxacin	2009
[Levofloxacin in patients in the ICU. Factors influencing the choice of dose and its use in combined therapy]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2004, Volume: 17, Issue:1 Topics: Anti-Infective Agents; Critical Care; Drug Therapy, Combination; Humans; Infections; Intensive Care Units; Levofloxacin; Middle Aged; Ofloxacin	2004
Clinical application of levofloxacin for severe infections. Chemotherapy, 2006, Volume: 52, Issue:6 Topics: Anti-Infective Agents; Humans; Infections; Levofloxacin; Ofloxacin; Severity of Illness Index	2006